Abstract:
PROBLEM TO BE SOLVED: To provide an improved HIV protease inhibitor that is very potent, that has reduced side-effects and that is effective against resistant strains of HIV.SOLUTION: This invention relates to: a compound of formula (I) as the HIV protease inhibitor; or a pharmaceutically acceptable salt form, stereoisomer, ester, salt of the ester, prodrug, salt of the prodrug, or combination thereof.
Abstract:
The instant invention provides compounds of formula (I) or a pharmaceutically acceptable salt, prodrug, or ester thereof, useful in the inhibition of neuraminidase enzymes from disease-causing microorganisms, especially influenza neuraminidase, pharmaceutical formulations containing same, processes and intermediates for preparing said compounds, as well as methods of using said compounds, including preventing and treating diseases caused by microorganisms having said neuraminidase enzyme.
Abstract:
Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.
Abstract:
A compound of the formula (I) is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
Abstract:
Disclosed are compounds of formula (I), (II) or (III) which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
Abstract:
Enantiomerically enriched compounds having the absolute stereochemistry of the formula (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
Abstract:
Un compuesto que tiene la fórmula (V)**Fórmula** o una forma de sal farmacéuticamente aceptable, estereoisómero, éster, sal de un éster, o combinación de éstos, enel que X es O, S o NH; Y es O, S o NH; R es alquilo, alquenilo, cicloalquilo, cicloalquenilo, cicloalquilalquilo, cicloalquenilalquilo, arilalquilo o heteroarilalquilo;en el que cada R está sustituido con 0, 1 ó 2 sustituyentes seleccionados del grupo que consiste en alquilo,alquenilo, alquinilo, ciano, halo, formilo, nitro, hidroxi, alcoxi, -NH2, -N(H)alquilo, -N(alquilo)2, -C(>=O)OH,-C(>=O)Oalquilo, haloalquilo, hidroxialquilo y alcoxialquilo; R1 es ORa, -OSO2Ra, -OSO3Ra, -OPO3Ra, -OC(>=O)C(H)(R1a)NRaRb o -OC(>=O)C(H)(R1a)N(H)C(O)ORa;R1a es hidrógeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroarilo oheteroarilalquilo; en el que cada R1a está sustituido con 0, 1 ó 2 sustituyentes seleccionados independientemente delgrupo que consiste en halo, alquilo, alquenilo, alquinilo, -ORa, -SRa, -SORa, -SO2Ra, -SO2NRaRb, -C(>=O)Ra, -NRaRb,-N(Rb)C(>=O)Ra, -N(Rb)C(>=O)ORa, -N(Rb)SO2Ra, -N(Ra)SO2NRaRb, -N(Rb)C(>=NH)NRaRb, -N(Rb)C(>=O)NRaRb,-C(>=O)NRaRb y -C(>=O)ORa; R2 es H; R3 es alquilo, haloalquilo, alquenilo, haloalquenilo, alquinilo, haloalquinilo, cicloalquilo, cicloalquenilo,cicloalquenilalquilo, cicloalquilalquilo, heterociclo, heterocicloalquilo, heteroarilo, heteroarilalquilo, arilo, arilalquilo,hidroxialquilo, alcoxialquilo, haloalcoxialquilo, -alquiloSRa, -alquiloSORa, -alquiloSO2Ra, -alquiloNRaRb,-alquiloN(Rb)C(>=O)ORa, -alquiloN(Rb)C(>=O)Ra, -alquiloN(Rb)SO2Ra o -alquiloN(Rb)SO2NRaRb; en el que cada uno delos restos cicloalquilo, cicloalquenilo, arilo, heteroarilo, heterociclo, cicloalquilo del cicloalquilalquilo, restocicloalquenilo del cicloalquenilalquilo, resto heterociclo del heterocicloalquilo, resto heteroarilo del heteroarilalquilo,resto arilo del arilalquilo está sustituido independientemente con 0, 1, 2 ó 3 sustituyentes seleccionadosindependientemente del grupo que consiste en halo, nitro, ciano, formilo, alquilo, alquenilo, alquinilo, hidroxi, alcoxi,-SH, -S(alquilo), -SO2(alquilo), -NH2, -N(H)(alquilo), - N(alquilo)2, -N(H)C(>=O)alquilo, -N(alquilo)C(>=O)alquilo,-C(>=O)OH, -C(>=O)O(alquilo), -C(>=O)NH2, -C(>=O)N(H)(alquilo), -C(>=O)N(alquilo)2, -C(>=O)alquilo, haloalquilo,hidroxialquilo, alcoxialquilo, cianoalquilo, formilalquilo, nitroalquilo, -alquiloSH, -alquiloS(alquilo), -alquiloSO2(alquilo),-alquiloNH2, -alquiloN(H)(alquilo), -alquiloN(alquilo)2, -alquiloN(H)C(>=O)alquilo, -alquiloN(alquilo)C(>=O)alquilo,-alquiloC(>=O)OH, -alquiloC(>=O)O(alquilo), -alquiloC(>=O)NH2, -alquiloC(>=O)N(H)(alquilo), -alquiloC(>=O)N(alquilo)2,-alquiloC(>=O)alquilo y R3a.
Abstract:
Azacyclosteroid histamine-3 receptor ligands, pharmaceutical compositions comprising such compounds, and methods for using such compounds and compositions are described herein.
Abstract:
Un compuesto de formula: o una de sus sales farmacéuticamente aceptables o formas radiomarcadas, donde: mes0º1; uno de R1 yR2 es hidrógeno, acilo, aciloxi, alquenilo, alcoxi, alcoxialcoxi, alcoxialquilo, alcoxicarbonilo, alcoxiimino, alcoxisulfonilo, alquilo, alquilcarbonilo, alquilsulfonilo, alquinilo, amido, carboxi, ciano, cicloalquilo, fluoroalcoxi, haloalcoxi, haloalquilo, halógeno, hidroxi, hidroxialquilo, mercapto, nitro, alquiltio, -NRARB, (NRARB) carbonilo, -SO2N (R14a) (R14b), -N (R14a) SO2 (R14b), un grupo de fórmula -L2-R6, o un grupo de fórmula -L3a-R6a-L3b-Rab; el otro de R1 yR2 se selecciona del grupo que consiste en hidrógeno, ciano, halógeno, alquilo, cicloalquilo, fluoroalquilo, alcoxi, alcoxialquilo, fluoroalcoxi, alquiltio, -SO2N (R14a) (R14b), y -N (R14a) SO2 (R14b); R3a yR3b se seleccionan cada uno independientemente del grupo que consiste en hidrógeno, ciano, halógeno; alquilo, cicloalquilo, fluoroalquilo, alcoxi, alcoxialquilo, fluoroalcoxi, alquiltio, -SO2N (R14a) (R14b), y -N (R14a) SO2 (R14b); R4 yR5 se seleccionan cada uno independientemente del grupo que consiste en alquilo, fluoroalquilo, hidroxialquilo, alcoxialquilo, y cicloalquilo;o R4 y R5 tomados junto con el átomo de nitrógeno al que están anclados forman un anillo aromático; R6 es arilo, heterociclo o heterocicloalquilo; R6a es arilo o heterociclo;R6b es arilo o heterociclo;L es un enlace o alquileno; L2 es un enlace, -O-, alquileno, -C (=O) -, -S-, -SO2N (R14a) -, -N (R14a) SO2-, -C (O) N (R14a) -, -N (R14a) C (O) -, o -N (R15) -;L3a yL3b se seleccionan cada uno independientemente del grupo que consiste en un enlace, -O-, alquileno, -C (=O) -, -S-, -SO2N (R14a) -, -N (R14a) SO2--, -C (O) N (R14a) -, -N (R14a) C (O) -, y -N (R15) -;R10 se selecciona del grupo que consiste en hidrógeno, ciano, fluoro, hidroxi, y alquilo; R14a yR14b se seleccionan cada uno independientemente en cada aparición del grupo que consiste en hidrógeno, alquilo, y cicloalquilo; R se selecciona del grupo que consiste en hidrógeno, alquilo, acilo, alcoxicarbonilo, y (R14a) (R14b) NC (O) -;y RA y RB se seleccionan independientemente entre hidrógeno, alquilo, acilo, haloalquilo, alcoxicarbonilo, cicloalquilo, y formilo.
Abstract:
Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).